News
The system is developed under the leadership of Seoul National University Hospital professor Chang-Wook Jeong.
AstraZeneca's Phase 3 trial showed baxdrostat lowered systolic blood pressure in treatment-resistant hypertension with a ...
In addition to taking medication, paying attention to these habits can help maintain healthy blood pressure levels..resistant ...
David’s blood pressure was dangerously high until he received specialized care and renal denervation at BIDMC’s Complex ...
The scope of resistant hypertension has not been quantified, but clinical trials suggest it may affect up to 30 percent of people with high blood pressure.
Struggling to control high BP? Learn about resistant hypertension, its causes, and expert-approved ways to manage it. Get ...
6d
Zacks Investment Research on MSNAstraZeneca Meets All Key Goals in Phase III Hypertension Study
AstraZeneca AZN reported positive top-line results from a late-stage study evaluating the safety, tolerability and efficacy ...
In a new clinical practice guideline, the Endocrine Society advises universal screening of those with hypertension by ...
“Baxdrostat BaxHTN Phase III trials on patients with uncontrolled or treatment-resistant hypertension demonstrated a ...
White-coat hypertension may represent another possible cause of pseudo-resistant hypertension, which needs to be properly identified. The prognostic significance of this condition, however, is ...
Resistant hypertension is nearly twice as prevalent among patients with systemic lupus erythematosus than in the general population, according to recent findings in Arthritis Care & Research ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results